Gilead Sciences (GILD) Misses Q1 EPS by 10c
Tweet
Share
E-mail
Get Alerts GILD Hot Sheet
Price: $136.36 +5.21%
EPS Growth %: -464.2%
Financial Fact:
Product sales: 7.41B
Today's EPS Names:
HELE, PSMT, LEVI, More
EPS Growth %: -464.2%
Financial Fact:
Product sales: 7.41B
Today's EPS Names:
HELE, PSMT, LEVI, More
Join SI Premium – FREE
Gilead Sciences (NASDAQ: GILD) reported Q1 EPS of $3.03, $0.10 worse than the analyst estimate of $3.13. Revenue for the quarter came in at $7.8 billion versus the consensus estimate of $8.08 billion. Gilead Sciences reaffirmed FY2016 guidance.
For earnings history and earnings-related data on Gilead Sciences (GILD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- HSBC Upgrades Gilead Sciences (GILD) to Buy
- Goldman Sachs Starts Banco de Sabadell SA (SAB:SM) (BNDSF) at Sell
- Goldman Sachs Downgrades Banco Comercial Portugues (BCP:LI) (BPCGF) to Neutral
Create E-mail Alert Related Categories
Earnings, Guidance, Hot EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
